Cargando…
Therapeutic combination silencing VEGF and SOX10 increases the antiangiogenic effect in the mouse melanoma model B16-F10 – in vitro and in vivo studies
INTRODUCTION: Gene therapy is an innovative form of treatment of genetic diseases, in which psiRNA molecules silencing specific genes are applied. AIM: The study evaluated the anti-tumour effect of psiRNA silencing preparations of the vascular endothelial growth factor (VEGF) and Sry-related HMG-Box...
Autores principales: | Bogusławska-Duch, Joanna, Ducher-Hanaka, Magdalena, Zajkowska, Agnieszka, Czajka, Milena, Małecki, Maciej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610042/ https://www.ncbi.nlm.nih.gov/pubmed/34849139 http://dx.doi.org/10.5114/ada.2021.110461 |
Ejemplares similares
-
Resistance of melanoma cells to anticancer treatment: a role of vascular endothelial growth factor
por: Bogusławska-Duch, Joanna, et al.
Publicado: (2020) -
Xanthomicrol Exerts Antiangiogenic and Antitumor Effects in a Mouse Melanoma (B16F10) Allograft Model
por: Ghazizadeh, Foad, et al.
Publicado: (2020) -
Sox10 Controls Migration of B16F10 Melanoma Cells through Multiple Regulatory Target Genes
por: Seong, Ikjoo, et al.
Publicado: (2012) -
SOX10-MITF pathway activity in melanoma cells
por: Tudrej, Karol B, et al.
Publicado: (2016) -
Identification and functional analysis of SOX10 phosphorylation sites in melanoma
por: Cronin, Julia C., et al.
Publicado: (2018)